Phacilitate Leaders World

Conference speakers

Loading
Patricia Hurley

Patricia Hurley

Senior Director, PPD Consulting

As a Senior Director in PPD Consulting, Patricia provides product development and global strategic regulatory advice to external and internal clients, determining the most appropriate strategy for their projects. She acts as a point of contact to provide regulatory and product development consulting advice and expertise to advanced therapy developers in a partnership setting and is a founder and leader of PPD’s Advanced Therapy cross-functional expert working group.

Since joining PPD’s in 2010 as a manager in global regulatory development, Dr. Hurley has successfully supported many clients with global clinical trial authorization applications, marketing authorization applications and strategic consulting discussions in several disease areas, including rare diseases. She has taken part in multiple regulatory agency interactions and scientific advice meetings with clients to discuss their cell and gene therapy product development.

She is based in the PPD Cambridge office in the UK, belongs to The Organization for Professionals in Regulatory Affairs (TOPRA) and sits on the editorial board of Regulatory Rapporteur. Prior to joining PPD, Dr. Hurley was head of project management and biomarkers division at a London-based regulatory and product development consulting group where she undertook the full range of global regulatory activities. 

Dr. Hurley has a doctorate in molecular pharmacology and a bachelor’s in pharmacology and molecular genetics from University College Dublin, in Ireland.

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK